West Virginia · 2026 Regular Session · Bill
HB 4640: Relating to drugs and adding a provision relating to the scheduling of crystalline polymorph psilocybin approved by the Food and Drug Administration
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
HB 4640 is a bill introduced in the West Virginia House on January 21, 2026. According to its official title, it concerns: Relating to drugs and adding a provision relating to the scheduling of crystalline polymorph psilocybin approved by the Food and Drug Administration. Primary sponsor: Evan Worrell (Republican). It lists 1 additional sponsor. Most recent recorded action (February 2, 2026): On 1st reading, House Calendar.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Republican 2
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Evan Worrell | Primary sponsor | Republican | House | 23 |
| Mike Hite | Co-sponsor | Republican | House | 92 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- On 1st reading, House Calendar
- Placed on House Calendar
- Postponed on 1st reading, Special Calendar, until January 30, 2026
- On 1st reading, Special Calendar
- By substitute, do pass
- Markup Discussion
- To House Health and Human Resources
- Introduced in House
- To Health and Human Resources
- Filed for introduction